Author Archives: Susan Poon

Added questions to “General Management of Psychiatric Disorders” and “Psychopharmacology”.

Added questions to “Psychiatric DDx, Epidemiology, Comorbidites, & Complications” and “Formulation”.

Added questions to “DSM-5 Criteria (Comprehensive)”. Replaced “Clinical Features of Neurodevelopmental and Neurocognitive Disorders” with new test “DSM-5 Criteria Neurocognitive Disorders”. Added test “General Management of Psychiatric Disorders”.

Edited questions for “DSM-5 Criteria Psychotic Disorders” and “DSM-5 Criteria (Comprehensive)”

Added questions to “Psychotropic Drug Classes, MOA, and Names (Level 2)”. Merged broad-review tests “Epidemiology” and “Psychiatric DDx, Comorbidities, & Complications” together. Merged “Psychotropic Drug Classes, MOA, and Names (Level 2)”, “Psychotropic Drug Indications, Contraindications, Side Effects, and DDI”, and “Psychotropic Drug Dosing” together into “Psychopharmacology”.

Added questions to “Psychotropic Drug Indications, Contraindications, SE, and DDI”. Added new handout “Bow Valley College LMC1 Part 2/3 (Management) Worksheet”.

Added new Bow Valley teaching handout “Bow Valley College MCCQE Part 1 Supplementary Teaching Handout re Management”

Added new test “Psychotropic Drug Class, MOA, and Names (Level 2)”.

Added questions to “Psychotropic Drug Indication, Contraindication, Side Effects, and DDI” and “Formulation”.

Added new test “DSM-5 Criteria Disruptive, Impulse-Control, and Conduct Disorders”. Psychiatry resident level tests recategorized into “Broad Topic Review” vs “Specific Topic Review”. Edited questions for “Overview of Bipolar Disorder Management per CANMAT 2018 Guidelines”